Skip Nav Destination
Article navigation
Education|
November 1989
Alfentanil Clearance is Independent of the Polymorphic Debrisoquin Hydroxylase
Thomas K. Henthorn, M.D.;
Thomas K. Henthorn, M.D.
*Assistant Professor of Anesthesia.
Search for other works by this author on:
Michael J. Avram, Ph.D.;
Michael J. Avram, Ph.D.
†Associate Professor of Anesthesia.
Search for other works by this author on:
Tom C Krejcie, M.D.
Tom C Krejcie, M.D.
‡Assistant Clinical Professor of Anesthesia.
Search for other works by this author on:
Anesthesiology November 1989, Vol. 71, 635–639.
Citation
Thomas K. Henthorn, Michael J. Avram, Tom C Krejcie; Alfentanil Clearance is Independent of the Polymorphic Debrisoquin Hydroxylase. Anesthesiology 1989; 71:635–639 doi: https://doi.org/10.1097/00000542-198911000-00002
Download citation file:
Citing articles via
Most Viewed
Related Articles
Pharmacogenetic Determinants of Human Liver Microsomal Alfentanil Metabolism and the Role of Cytochrome P450 3A5
Anesthesiology (March 2005)
Is the Metabolism of Alfentanil Subject to Debrisoquine Polymorphism? A Study Using Human Liver Microsomes
Anesthesiology (October 1988)
Assessment of Cytochrome P450 3A4 Activity during the Menstrual Cycle Using Alfentanil as a Noninvasive Probe
Anesthesiology (July 1997)
ALFENTANIL CLEARANCE IS INDEPENDENT OF THE POLYMORPHIC DEBRISOQUIN HYDROXYLASE
Anesthesiology (September 1988)
